Surface Bioadvances

Surface Bioadvances was a biotechnology company specializing in advanced surface modification technologies for medical devices and life science research. Founded by Dr. Buddy Ratner and colleagues from the University of Washington, the company developed proprietary plasma-based processes to enhance the biocompatibility and performance of various materials. Their technology focused on controlling protein adsorption and cell-surface interactions, which are critical for the success of implants and diagnostic tools. The company's core expertise lay in radio-frequency glow discharge (RFGD) plasma deposition, allowing for the creation of ultra-thin, stable coatings. In 2001, the company was acquired by SurModics to expand its portfolio of surface-active coatings and delivery technologies.